BioMimetic Therapeutics, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 12   

Articles published

BMTI 0.0000
price chart
Zimmer purchases biologic therapeutics company ETEX
"Zimmer is committed to developing the most comprehensive range of biologic therapies for patients suffering from musculoskeletal joint disease, from early intervention solutions like Gel-One Cross-linked Hyaluronate and joint preservation solutions ...
Related articles »  
Breaking Biodefense News: Aethlon Medical (NASDAQ:OTCQB: AEMD ...
SAN DIEGO - September 22, 2014 (Investorideas.com newswire) Aethlon Medical, Inc. (NASDAQ:OTCBB:AEMD), the pioneer in developing targeted therapeutic devices to address infectious disease, cancer and other life-threatening conditions, disclosed today ...
Aethlon Medical Receives Notice of DARPA Contract Renewal  Stockhouse
Related articles »  
LENSAR Appoints Charlie Federico and Carmen Bringgold to Board of Directors
... including Board Chairman, Compensation and Governance Committee Chairman and member of the Audit Committee of MAKO Surgical Corp (acquired by Stryker in 2013 for $1.65 billion), as well as similar roles BioMimetic Therapeutics Inc. (acquired by ...
Related articles »  
Frost & Sullivan Confers Technology Innovation Leadership Award on ADOCIA ...
"The company constantly strategizes to boost the suitability and ease of use of BioChaperone´┐Ż so as to make the therapeutic proteins in the market accessible to the masses." ... In its pursuit to increase the drug uptake by cancerous cells, the company ...
Related articles »  
Pharma and Omics Journals to Address Global Challenges during Open Access ...
OMICS Group International invites researchers, authors and academicians across the globe to participate in the 'Open Access Week' by actively contributing their research outcome as articles to OMICS Group Pharma and Omics Journals from 20-26th ...
Related articles »  
Chemistry for Global Development during the Open Access Week
OMICS Group International invites researchers, authors and academicians across the globe to participate in the 'Open Access Week' by actively contributing their research outcome as articles to OMICS Group Chemistry Journals from 20-26th October, 2014.
Related articles »